{"schema_version":"secwatch.filing_event.v1","accession":"0001000228-23-000041","form_type":"8-K","ticker":"HSIC","cik":"0001000228","company_name":"HENRY SCHEIN INC","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.806642+00:00","generated_at":"2026-06-12T03:35:25.592342+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Henry Schein Q2 GAAP EPS $1.06, Non-GAAP $1.31; Revenue $3.1B; Affirms FY Guidance","bullets":["GAAP net income $140M ($1.06/diluted share) vs Q2 2022 $160M ($1.16); non-GAAP $173M ($1.31) vs $179M ($1.30).","Total sales $3.1B (+2.3%); internal sales ex-PPE/COVID test kits +3.3% in local currencies; global dental +5.6% to $2.0B.","PPE & COVID test kit sales $163M, down $96M YoY; impact on EPS estimated at $0.08/diluted share.","FY 2023 non-GAAP EPS guidance reaffirmed at $5.18-$5.35; PPE sales now expected to decline 25%-30% (prior ~20-25%).","Committed over $1B to acquisitions YTD; closed new $750M credit facility in July 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001000228-23-000041","json":"https://secwatch.observer/filing/0001000228-23-000041.json","markdown":"https://secwatch.observer/filing/0001000228-23-000041.md","text":"https://secwatch.observer/filing/0001000228-23-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000228/000100022823000041/0001000228-23-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000228/000100022823000041/hsic-20230807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T03:35:25.592342+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"086e1db4ac0bd72ff0d53882cd409135638e2048","claim":"HENRY SCHEIN INC reported the six months ended July 1, 2023 results: revenue $6.2 billion. Guidance reaffirmed.","evidence_excerpt":"solutions, and by revenue cycle management solutions driven by a higher volume of e-claims. Year -to-Date Financial Results ● Total net sales for the first half of 2023 were $6.2 billion, a decrease of 0.8% compared with the first half of 2022. The 0.8% decrease included a 2.0% internal decrease in local currencies, 2.2% growth from acquisitions, and a 1.0%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1000228/000100022823000041/0001000228-23-000041-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the six months ended July 1, 2023"},{"label":"Revenue","value":"$6.2 billion"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"794064fbd36f9845dc05c30018b278e588aa57f4","claim":"HENRY SCHEIN INC reported the second quarter ended July 1, 2023 results: revenue $3.1 billion, net income $140 million, EPS $1.06 per diluted share. Guidance reaffirmed.","evidence_excerpt":"Schein’s leadership in the markets that we serve and to deliver long-term sustainable shareholder value.” Second-Quarter Financial Results ● Total net sales for the quarter were $3.1 billion, an increase of 2.3% compared with the second quarter of 2022. The 2.3% increase included a 0.2% decrease in local currencies excluding acquisitions, 2.9% growth from","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1000228/000100022823000041/0001000228-23-000041-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter ended July 1, 2023"},{"label":"Revenue","value":"$3.1 billion"},{"label":"Net income","value":"$140 million"},{"label":"EPS","value":"$1.06 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}